← Leaderboards
Kathleen Louise Gabrielson
Johns Hopkins University
$4,202,516
Attributed
$4,385,484
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $679K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,385,484 · 6
By mechanism
R01$2,314,945 · 1
P01$959,345 · 2
R21$836,742 · 2
R43$274,452 · 1
Top collaborators
- Raghu S Pandurangi1 shared
- Martin G Pomper1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Joshua M Hare$39,853,111
- Viswanathan Natarajan$24,234,784
- Catherine Simpson$1,574,335
- Casey Marie Rebholz$5,201,333
- David M. Loeb$4,776,895
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAnimalsToxic EffectMolecularCancer TherapyPharmaceutical PreparationsCancer PatientHeartRattusTherapeutic AgentsPublishingDoxorubicinCardiotoxicityCellsCancer CellCell DeathCardiomyopathiesIn VivoNovel StrategiesPathway InteractionsBaseCardiacDoseMonitor
Grant awards (15)
Core 1: Animal Models, Pathology and Tissue$321,148
P01 · FY2025 · CA · contact PI
Core 1: Animal Models, Pathology and Tissue$216,032
P01 · FY2024 · CA · contact PI
Core 1: Animal Models, Pathology and Tissue$227,403
P01 · FY2023 · CA · contact PI
Differentially methylated gene regions (DMRs) induced by doxorubicin in heart: significance and clinical application$204,688
R21 · FY2022 · HL · contact PI
Differentially methylated gene regions (DMRs) induced by doxorubicin in heart: significance and clinical application$245,625
R21 · FY2021 · HL · contact PI
Imaging cell death in a preclinical rat model with metastatic osteosarcoma$172,735
R21 · FY2019 · CA · contact PI
Imaging cell death in a preclinical rat model with metastatic osteosarcoma$213,694
R21 · FY2018 · CA · contact PI
Theranostics of Reduction of Cardiotoxicity Using Targeted Apoptosis Activation Technology$274,452
R43 · FY2017 · CA
Signal Transduction in the Heart after Cancer Therapy$405,900
R01 · FY2012 · HL · contact PI
Signal Transduction in the Heart after Cancer Therapy$410,000
R01 · FY2011 · HL · contact PI
Histology$194,762
P01 · FY2011 · HL · contact PI
Signal Transduction in the Heart after Cancer Therapy$410,000
R01 · FY2010 · HL · contact PI
Signal Transduction in the Heart after Cancer Therapy$410,000
R01 · FY2009 · HL · contact PI
Signal Transduction in the Heart after Cancer Therapy$269,045
R01 · FY2009 · HL · contact PI
Signal Transduction in the Heart after Cancer Therapy$410,000
R01 · FY2008 · HL · contact PI